
KALA BIO Inc
Kala Pharmaceuticals develops treatments for the prevention and diagnosis of diseases of the eye
Stock Performance Snapshot
Analyst Rating
Analysts suggest purchasing KALA BIO Inc's stock with a target price of $11.75, indicating strong growth potential.
Financial Health
KALA BIO Inc is generating strong cash flow per share, indicating healthy financial performance.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring KALA
Education in the Spotlight
This carefully selected group of stocks features companies that could benefit from McGraw Hill's upcoming $4.2 billion IPO. Our professional analysts have identified these educational publishers, digital platforms, and service providers as potential beneficiaries of renewed investor interest in the education sector.
Published: July 15, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Clinical Milestones Ahead
Progress in trials or approvals can be a key value driver, though outcomes are uncertain and timing can shift.
Financing Sensitivity
Small biotech firms often need fresh capital; fundraising can dilute existing holders and influence the share price.
Research Due Diligence
Check filings, cash runway and management commentary to understand catalysts and the company’s strategic direction.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Eli Lilly and Company
Eli Lilly & Co is a global pharmaceutical company that develops, manufactures and markets human prescription drugs.
Johnson & Johnson
Johnson & Johnson is a multinational conglomerate pharmaceutical, medical devices, and consumer packaged goods company.
AbbVie Inc.
Abbvie is a research-based biopharmaceutical company that develops and markets advanced therapies to address complex medical conditions.